Postdoctoral Research Fellow
Lavanya Choppavarapu
Postdoctoral Research Fellow
Mentor: Dr. Victor Jin
Phone: 2108634383
Email: lavanya.nimhans@gmail.com
Education
2017 | Ph.D. | National Institute of mental health and neurosciences (NIMHANS) |
2009 | MSc (Biotechnology) | Bangalore University |
2007 | BSc (Biotechnology) | Sri Venkateswara University |
Professional Memberships
2020 | American Association for Cancer Research (AACR) |
Publications
1. Lavanya C, Venkataswamy MM, Sibin MK, Srinivas Bharath MM, Chetan GK. Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells. Cytotechnology. 2018, 70(4):1143-1154.
2.Lavanya C, Sibin MK, Srinivas Bharath MM, Manoj MJ, Venkataswamy MM, Bhat DI, Narasinga Rao KV, Chetan GK. RNA interference mediated downregulation of human telomerase reverse transcriptase (hTERT) in LN18 cells. Cytotechnology. 2016, 68(6):2311-2321.
3. Jeru-Manoj Manuel, Debarati Ghosh, Narasinga Rao KVL , Sibin M K, Venkatesh HN , Lavanya Ch, Arati S, Dhananjaya I Bhat, Srinivas Bharath MM, Chetan GK, Role of Concurrent Methylation Pattern of MGMT, TP53 and CDKN2A Genes in the Prognosis of High Grade Glioma, J Carcinog Mutagene. 2016, 7:1.
4. Sibin M K, ChLavanya, Dhananjaya I Bhat, NarasingaRao, Geethashree N, Vibhuti W, Chetan G K, CD133 and BMI1 expressions and its prognostic role in primary glioblastoma, Journal of Genetics. 2015, 94(4):689-96.
5. Sibin M K, Dhananjaya I Bhat, ChLavanya, Arati S and Chetan GK, Over-expression and lack of copy number variation in BMI-1 gene in Human glioma from Indian Population. Oncology letters. 2015, 10(5):3318-3322.
6. Sibin M K, Dhananjaya I Bhat, K V L NarasingaRao, ChLavanya, G K Chetan , CDKN2A (p16) mRNA decreased expression is a marker of poor prognosis in malignant high grade glioma, Tumor Biol. 2015, 36(10):7607-14.
7. Sibin M K Dhananjaya I. Bhat , Ch Lavanya , M. Jeru Manoj , S. Aakershita G. K. Chetan, CDKN2A exon-wise deletion status and novel somatic mutations in Indian glioma patients. Tumor Biol. 2014, 35:1467–1472.
8.Yang Y, Choppavarapu L, Fang K, Naeini AS, Nosirov B, Li J, Yang K, He Z, Zhou Y, Schiff R, Li R, Hu Y, Wang J, Jin VX. The 3D genomic landscape of differential response to EGFR/HER2 inhibition in endocrine-resistant breast cancer cells. Biochim Biophys Acta Gene Regul Mech. 2020 Nov;1863(11):194631. doi: 10.1016/j.bbagrm.2020.194631. Epub 2020 Sep 19. PMID: 32956836; PMCID: PMC7686120.
9.Choppavarapu L, Kandi SM. Circulating microRNAs as Potential Biomarkers in Glioma: A Mini Review. Endocr Metab Immune Disord Drug Targets. 2020 Jul 30. doi: 10.2174/1871530320666200730230422. Epub ahead of print. PMID: 32744979.